Xponential Fitness Analyst Price Targets - Benzinga

Xponential Fitness Inc

XPOFNYSE

Trade with Public

Trade with Public

$4.69

-0.13-2.7%

Ult. Agg.: Oct 14, 12:50 PM

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Confronta Opzioni Rapporto azionario

Xponential Fitness Analyst Price Targets - Benzinga

Xponential Fitness Analyst Price Targets

Wall Street analyst price targets and consensus rating for Xponential Fitness (XPOF).

Price Target Range — 11 Quarters

Analyst Consensus — 13 Analysts

3Buy

10Hold

Consensus RatingNeutral# Analysts13Avg. Consensus PT$12Upside to Avg. PT+148.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 16, 2026	UBS	Arpine Kocharyan	PT Cut	Neutral	$7→$5
Aug 10, 2026	Roth Capital	George Kelly	PT Cut	Neutral	$7→$5
Aug 10, 2026	B. Riley Securities	Jeff Van Sinderen	PT Cut	Neutral	$6→$5
Aug 7, 2026	Guggenheim	John Heinbockel	Downgrade	Buy→Neutral	—
Mar 19, 2026	Raymond James	Joseph Altobello	Downgrade	Strong Buy→Market Perform	—
Mar 12, 2026	Keybanc	Noah Zatzkin	Initiate	Sector Weight	—
Mar 2, 2026	Guggenheim	John Heinbockel	PT Cut	Buy	$12→$10
Feb 27, 2026	Baird	Jonathan Komp	PT Cut	Neutral	$8→$7
Nov 21, 2025	Stifel	Chris O'Cull	PT Cut	Hold	$10→$8
Nov 10, 2025	Guggenheim	John Heinbockel	PT Cut	Buy	$13→$12
Oct 17, 2025	UBS	Arpine Kocharyan	Initiate	Neutral	$8
Aug 8, 2025	Raymond James	Joseph Altobello	PT Cut	Strong Buy	$15→$14
May 12, 2025	Guggenheim	John Heinbockel	Maintained	Buy	$13
May 9, 2025	Raymond James	Joseph Altobello	PT Cut	Strong Buy	$16→$15
Mar 14, 2025	Lake Street	Ryan Meyers	PT Cut	Buy	$20→$16
Mar 14, 2025	Piper Sandler	Korinne Wolfmeyer	PT Cut	Neutral	$16→$9
Mar 14, 2025	Stifel	Chris O'Cull	Downgrade	Buy→Hold	$20→$12
Mar 14, 2025	B. Riley Securities	Jeff Van Sinderen	PT Cut	Neutral	$12→$9
Jan 23, 2025	Northland Capital Markets	Owen Rickert	Initiate	Market Perform	$18
Jan 6, 2025	Piper Sandler	Korinne Wolfmeyer	PT Raise	Neutral	$12→$16

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
UBS Maintains Neutral on Xponential Fitness, Lowers Price Target to $4.5

UBS analyst Arpine Kocharyan maintains Xponential Fitness (NYSE:XPOF) with a Neutral and lowers the price target from $7 to $4.5.

Benzinga Newsdesk

PRO
Roth Capital Maintains Neutral on Xponential Fitness, Lowers Price Target to $5

Roth Capital analyst George Kelly maintains Xponential Fitness (NYSE:XPOF) with a Neutral and lowers the price target from $7 to $5.

Benzinga Newsdesk

PRO
B. Riley Securities Maintains Neutral on Xponential Fitness, Lowers Price Target to $5

B. Riley Securities analyst Jeff Van Sinderen maintains Xponential Fitness (NYSE:XPOF) with a Neutral and lowers the price target from $6 to $5.

Benzinga Newsdesk

PRO
Guggenheim Downgrades Xponential Fitness to Neutral

Guggenheim analyst John Heinbockel downgrades Xponential Fitness (NYSE:XPOF) from Buy to Neutral.

Benzinga Newsdesk

This Xponential Fitness Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday

Avi Kapoor

PRO
Raymond James Downgrades Xponential Fitness to Market Perform

Raymond James analyst Joseph Altobello downgrades Xponential Fitness (NYSE:XPOF) from Strong Buy to Market Perform.

Benzinga Newsdesk